EcoDrugPlus

Solute Carrier Family 6 Member 2

Ensembl ID : ENSPFOG00000016149
Gene Symbol: SLC6A2
3 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSPFOG00000016403
Gene Symbol: SLC6A3
1 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSPFOG00000009254
Gene Symbol: SLC6A4A
1 Cross references
201 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSPFOG00000019486
Gene Symbol: SLC6A9
1 Cross references
208 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSPFOG00000006131
Gene Symbol: SLC9A3
3 Cross references
234 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSPFOG00000020710
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSPFOG00000017950
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSPFOG00000004070
Gene Symbol: SSTR3
2 Cross references
183 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSPFOG00000020774
Gene Symbol: SSTR5
1 Cross references
188 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSPFOG00000020395
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSPFOG00000000584
Gene Symbol: SYK
1 Cross references
194 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSPFOG00000023193
Gene Symbol: SYK
1 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).